黏附侵袭性大肠埃希菌在克罗恩病中的作用:术后复发模型的启示
该研究利用前瞻性多中心队列的术后复发模型,在手术标本(M0)和术后6个月内镜下新末端回肠(M6)检测黏附侵袭性大肠埃希菌(AIEC),发现M6新末端回肠AIEC检出率30.3%高于手术标本的14.9%(p<0.001),且AIEC阳性与早期回肠病变及术后内镜复发风险升高相关,支持AIEC参与回肠克罗恩病早期步骤。
要点
- 术后6个月新末端回肠AIEC检出率30.3%,高于手术标本的14.9%(p<0.001)。
- M6新末端回肠AIEC阳性者早期回肠病变(i1)发生率为41.6% vs 17.1%(aRR 3.49)。
- 手术标本AIEC阳性与i2b型及严重内镜术后复发风险升高相关。
核心结论
- 基于术后复发模型,数据支持AIEC参与回肠克罗恩病的早期步骤。
研究设计与样本
- 从前瞻性多中心手术克罗恩病患者队列中,在手术标本(M0,N=181例患者)和术后6个月结肠镜下的新末端回肠(n=119例/181例)进行AIEC鉴定,并用Rutgeerts指数对内镜术后复发分级。
主要发现
- M6新末端回肠AIEC检出率为30.3%,为手术标本14.9%的两倍(p<0.001)。
- M6新末端回肠AIEC阳性者早期回肠病变(i1)发生率为41.6% vs 无病变(i0)17.1%(aRR 3.49,95%CI 1.01至12.04,p=0.048)。
- M6新末端回肠AIEC阳性者回肠病变(i2b+i3)发生率为38.2% vs 无病变(i0)17.1%(aRR 3.45,95%CI 1.06至11.30,p=0.040)。
- 手术标本AIEC阳性预测i2b型内镜术后复发风险升高(aOR 2.54,95%CI 1.01至6.44,p=0.049)和严重内镜术后复发风险升高(aOR 3.36,95%CI 1.25至9.06,p=0.017)。
- 仅5.0%(6/119)患者M0和M6均AIEC阳性,43.7%(52/119)有AIEC阳性检测史(M0或M6)者回肠内镜术后复发风险升高(aOR 2.32,95%CI 1.01至5.39,p=0.048)、i2b型内镜术后复发风险升高(aOR 2.41,95%CI 1.01至5.74,p=0.048)和严重内镜术后复发风险升高(aOR=3.84,95%CI 1.32至11.18,p=0.013)。
关键数值与推荐
- AIEC定植与特定微生物群特征相关,包括瘤胃球菌(Ruminococcus gnavus)丰度增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We used the postoperative recurrence model to better understand the role of adherent and invasive Escherichia coli (AIEC) bacteria in Crohn's disease (CD), taking advantage of a well-characterised postoperative cohort. DESIGN: From a prospective, multicentre cohort of operated patients with CD, AIEC identification was performed within the surgical specimen (M0) (N=181 patients) and the neoterminal ileum (n=119 patients/181) during colonoscopy performed 6 months after surgery (M6). Endoscopic postoperative recurrence was graded using Rutgeerts' index. The mucosa-associated microbiota was analysed by 16S sequencing at M0 and M6. Relative risks or ORs were adjusted on potential confounders. RESULTS: AIEC prevalence was twofold higher within the neoterminal ileum at M6 (30.3%) than within the surgical specimen (14.9%) (p<0.001). AIEC within the neoterminal ileum at M6 was associated with higher rate of early ileal lesions (i1) (41.6% vs 17.1%; aRR 3.49 (95% CI 1.01 to 12.04), p=0.048) or ileal lesions (i2b+i3) (38.2% vs 17.1%; aRR 3.45 (95% CI 1.06 to 11.30), p=0.040) compared with no lesion (i0). AIEC within the surgical specimen was predictive of higher risk of i2b-endoscopic postoperative recurrence (POR) (aOR 2.54 (95% CI 1.01 to 6.44), p=0.049) and severe endoscopic POR (aOR 3.36 (95% CI 1.25 to 9.06), p=0.017). While only 5.0% (6/119) of the patients were AIEC-positive at both M0 and M6, 43.7% (52/119), patients with history of positive test for AIEC (M0 or M6) had higher risk of ileal endoscopic POR (aOR 2.32 (95% CI 1.01 to 5.39), p=0.048)), i2b-endoscopic postoperative recurrence (aOR 2.41 (95% CI 1.01 to 5.74); p=0.048) and severe endoscopic postoperative (aOR=3.84 (95% CI 1.32 to 11.18), p=0.013). AIEC colonisation was associated with a specific microbiota signature including increased abundance of Ruminococcus gnavus. CONCLUSION: Based on the postoperative recurrence model, our data support the idea that AIEC are involved in the early steps of ileal CD. TRIAL REGISTRATION NUMBER: NCT03458195.
引用
- Buisson A, Sokol H, Hammoudi N, et al. Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model. Gut. 2022. PMID: 35361684. doi:10.1136/gutjnl-2021-325971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。